China News Service, April 27th. In response to the issue of "Oncologists in the Third Hospital of Beijing Medical University report on the shady of tumor treatment", Jiao Yahui, director of the Medical Administration and Hospital Administration of the National Health Commission, pointed out on the 27th that the National Health Commission clearly mentioned , The situation of Qinghai patients with clear points, organize the National Cancer Center and authoritative experts in related fields in China to conduct expert and peer review on the entire treatment process of the case. After expert and peer review, it is believed that the treatment is The principle still basically conforms to the norm.
As for the issues that reflect gene sequencing, genetic testing, and NK cell therapy, Jiao Yahui pointed out that the National Health Commission also asked the Shanghai Municipal Health Commission to investigate, and the results of the investigation have not yet come out.
"If we discover violations of the laws and regulations of the exchange of benefits and transfer of benefits, we will never protect shortcomings and will never evade, and will deal with them seriously in accordance with laws and regulations."
The National Health Commission held a press conference on the 27th. Some reporters asked questions. Recently, we have seen news circulating on the Internet that the oncologists of the Third Hospital of Beijing Medical University reported shady tumor treatment. Does the National Health Commission have an investigation result on this matter?
How to further standardize tumor treatment in the next step?
Jiao Yahui pointed out that the National Health Commission attached great importance to this news after it paid attention to it. On the one hand, it contacted the Third Hospital of Beijing Medical University, and the third hospital of Beijing Medical University and the doctor, and asked the doctor to provide us with more detailed information. Investigate and verify the problems reflected in it.
Regarding the cases of Qinghai patients clearly mentioned and pointed out, we also organize the National Cancer Center and domestic authoritative experts in related fields to conduct expert and peer review on the entire treatment process of the case. After expert and peer review, It is believed that during the entire treatment process, the principles of treatment are basically in line with the norms. As for the problems reflected in it, such as gene sequencing, genetic testing, and NK cell therapy, whether there is improper exchange of benefits during this process, the National Health Commission The Shanghai Municipal Health Commission was also invited to conduct an investigation. The results of this investigation have not yet come out.
Jiao Yahui emphasized that the National Health Commission requires the Shanghai Municipal Health Commission during the investigation process to find any violations of the laws and regulations of the exchange of benefits and transfer of benefits, we will never protect our shortcomings and will never avoid it, and will deal with it severely in accordance with laws and regulations. .
At the same time, Jiao Yahui added that my country has already established a series of work arrangements for the standardized diagnosis and treatment of tumors, and has also issued corresponding technical specifications, including diagnosis and treatment specifications, diagnosis and treatment guidelines, and rational drug use guidelines. A quality control system has also been established, including a code of conduct. We have established a monitoring and quality control system for the safety and standardization of drug application.
"In the next step, we will further increase our efforts in these areas, especially focusing on the implementation of the opinions on the promotion of rational use of drugs issued by the six departments approved by the State Council, and the promotion of rational medical inspections reviewed by the Central Deep Reform Commission last year. Guidance, this year we will also carry out special rectification actions in the industry for rational inspection, rational use of drugs, and rational treatment. Among them, standardized diagnosis and treatment of tumors is a key content, and we must increase the corresponding efforts." Jiao Yahui said.